Skip to main content

Efalizumab Biosimilar – Anti-ITGAL, CD11a mAb – Research Grade

Reference:
Size

100ug, 1MG

Isotype

IgG1, kappa

Brand

ProteoGenix

Product type

Primary Antibodies

Clonality

Monoclonal Antibody

Expression system

Mammalian cells

Applications

Elisa, WB

Product nameEfalizumab Biosimilar - Anti-ITGAL, CD11a mAb - Research Grade
SourceCAS 214745-43-4
SpeciesHumanized
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsEfalizumab,hu1124,ITGAL, CD11a,anti-ITGAL, CD11a
ReferencePX-TA1040
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Efalizumab Biosimilar - Anti-ITGAL, CD11a mAb - Research Grade

General information on Anti-ITGAL/CD11a(Homo sapiens) (Efalizumab) Monoclonal Antibody

Efalizumab is a recombinant monoclonal antibody to Human CD11A. Under the trade name Raptiva, it is a drug that was previously used to treat autoimmune diseases and was originally used to treat psoriasis. Efalizumab binds to the CD11a subunit of lymphocyte function-associated antigen 1 and inhibits lymphocyte activation and cell migration out of blood vessels into tissues. Efalizumab has been associated with fatal brain infections.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Efalizumab Biosimilar – Anti-ITGAL, CD11a mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

ITGAL recombinant protein
Antigen

ITGAL recombinant protein

PX-P5176 392$
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
Isotype Control

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

PTX17885 215$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products